Navigation Links
Scientists identify a novel mechanism for evolution of highly aggressive cancers
Date:6/27/2011

Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at A*STAR's Genome Institute of Singapore (GIS), and Principal Investigator Dr Wa Xian at A*STAR's Institute of Medical Biology (IMB), together with their counterparts from the Harvard Medical School, the Brigham and Women's Hospital in Boston, and the National University of Singapore, have made the striking finding that Barrett's esophagus[1] work, published online in the journal Cell on 24 June 2011, is essential to developing therapeutics for esophageal cancer., the precursor of the most deadly esophageal cancer[2], can form without mutations in a matter of a few days. The

The scientists discovered that Barrett's esophagus arises from a very small group of embryonic cells that exist in all adults at the junction of the esophagus and the stomach. In most people, these embryonic cells are restricted to that junction. However, if the esophagus becomes damaged by acid reflux, these embryonic cells rapidly grow to exploit this opportunity and form the unusual, intestine-like tissue of Barrett's esophagus.

Using an independent mouse model to test the origins of Barrett's metaplasia[3] in adult animals, the scientists examined the molecular properties and evolution of metaplasia in mice, as a means to speeding up the development of esophageal cancer therapies in human. As treatment for late stage esophageal cancer is challenging and largely palliative, a better knowledge of the earlier, precancerous stage of this disease, such as Barrett's esophagus, serves as a prerequisite to developing therapeutic approaches.

Dr Wa, corresponding author of the publication in Cell, noted that "the exciting feature of this work is that these embryonic cells are present in everyone and do not have to be mutated to become a major threat as a high-risk cancer precursor cell. Preliminary work in the lab suggests our findings in Barrett's esophagus provide a valid model to explain a subset of particularly aggressive cancers for which modern medicine does not have therapeutic options".

Another author of the work, Dr Ho Khek Yu, an endoscopic surgeon specializing in Barrett's esophagus and Head of the Department of Medicine at National University of Singapore, added "Recent efforts to prevent the formation of esophageal cancer by removing the cells forming Barrett's esophagus before they turn cancerous have met with considerable setbacks. The study suggests a new way to prevent esophageal cancers: target these embryonic cells before they can form Barrett's esophagus. If the method is successful, we will have eradicated one major risk factor of esophageal cancer."

Corresponding author Dr Frank McKeon of the GIS and Harvard Medical School said, "we now have a great deal of information about these unusual embryonic cells that give rise to Barrett's esophagus and are working with clinicians to develop novel monoclonal antibodies to eliminate these cells before they become malignant. This type of preventive therapy directed at the precursors of these cancers is the rational approach to stamping out the disease, which has risen five-fold in the last 30 years."

Dr Yusuke Yamamoto, a senior postdoctoral fellow at the GIS, expert in bioinformatics and stem cell biology, and co-first author of the publication, noted, "I am continually amazed by the speed with which mouse genetic models, bioinformatics, and stem cell biology come together in Singapore to provide such a vivid image of disease processes and identify genes that represent the most important prevention and therapeutic targets".

Profs Barbara Knowles and Davor Solter, Senior Principal Investigators of the Mammalian Development Laboratory at the Institute of Medical Biology in Singapore commented, "An excellent piece of scientific sleuthing with a tantalizing approach to cancer prevention".

Prof Lee Eng Hin, Executive Director of A*STAR's Biomedical Research Council, said, "The work is an excellent example of clinicians, bioinformaticians, stem cell biologists, and geneticists coming together in Singapore to understand disease processes. Cross-disciplinary collaborations between scientists and clinicians such as this will go far in establishing Singapore as Asia's Innovation Capital and a global research hub."


'/>"/>

Contact: Winnie Serah Lim
limcp2@gis.a-star.edu.sg
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related medicine news :

1. Singapore scientists discover how to control fate of stem cells
2. Scientists Zero In on Key Melanoma Links
3. Scientists develop first ever drug to treat Celtic gene in cystic fibrosis sufferers
4. Scientists Turn Memory On, Off in Rats With Flip of Switch
5. Scientists Pinpoint Parts of Brain That Help People Recognize Themselves
6. Several methods for early diagnosis of Alzheimers disease developed by European scientists
7. Scientists image beginning stages of ovarian cancer growth with time-lapse technique
8. Scientists identify key component in lethal lung cancer complication
9. Swine flu spread was much wider than first thought, scientists say
10. Einstein scientists find crucial molecule involved in spread of breast cancer
11. Scientists create humanized mouse model for hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Greener Hydroponics is now offering a large selection ... by professional organic farmers and nurseries according to Sales Manager Joe Steele who says, ... Our goal is to offer wholesale level pricing and ultra-fast shipping for growers of ...
(Date:4/28/2016)... , ... April 28, 2016 , ... In 2011, TIME ... in the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He ... Lab. He is also the Founder of BionX , a leader in the ...
(Date:4/28/2016)... Chicago, Illinois (PRWEB) , ... ... ... Inc., the leading provider of enterprise Data Center Infrastructure Management solutions, announces ... 14.5 focuses on feature enhancements in the area of capacity management and ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... One way ... say anything.” This is unfortunately true. But we toss the baby out with the ... single-page brief provides tips for identifying higher-quality studies and otherwise making better use of ...
(Date:4/28/2016)... ... 28, 2016 , ... USA Medical Card reminds us that May is National Stroke Awareness Month. ... fourth leading cause of death in the United States; someone has one every 40 seconds. ... in individuals under 65 years old. A stroke is when blood flow to the ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... , April 27, 2016 Transparency ... "Skincare Devices Market - Global Industry Analysis, Size, Share, ... the report, the global skincare devices market was valued ... to expand at a CAGR of 10.1% from 2015 ... Browse the full Skincare Devices Market (Treatment Device ...
Breaking Medicine Technology: